Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins.
about
Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasmaVaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variantsThe expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus.Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technologySubstitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibodyA human PrM antibody that recognizes a novel cryptic epitope on dengue E glycoprotein.Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice.Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry.Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoproteinNeutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape?Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challengeMultiantibody strategies for HIV.Analyses of Coronavirus Assembly Interactions with Interspecies Membrane and Nucleocapsid Protein ChimerasPositive reactions on Western blots do not necessarily indicate the epitopes on antigens are continuous.
P2860
Q27478384-F44BFD88-4B14-4CC3-AA74-05986F37E730Q28764574-5F143341-9579-4652-ABE5-07AC68C492BDQ33387723-3DF16ED1-5A22-452F-97BD-686F3010A2D9Q33688229-741BF189-5A48-4BD1-8D5D-5952F045C18DQ33897964-029C007D-CF7D-46E2-9351-519AC8687E2EQ34235005-3298C890-BAD3-45A5-B058-0BDAF76BDEC1Q35914462-62CC5D39-28B3-41E0-8D2B-9772EC7C3D13Q36315018-2E969734-7D8E-4FE9-877A-5823FB18EF9CQ36315168-251CC067-6CF9-4E20-BA0F-B52F2DBFDFEEQ36404194-52C84F10-59D9-4E27-B7BB-A23BCBE4272DQ36498144-96CBA495-DD9B-45CD-9271-C0BA7F148314Q38120526-037ABE53-9ECA-41BC-AC2F-FF8864F2B741Q38793264-B2290BA0-CBE9-4A12-9B2A-34B1DBB3EFE2Q45201742-2DE24EED-5C85-438B-A7E9-D9776D8B2E39
P2860
Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Monoclonal antibodies to SARS- ...... S, N, M and E viral proteins.
@ast
Monoclonal antibodies to SARS- ...... S, N, M and E viral proteins.
@en
Monoclonal antibodies to SARS- ...... S, N, M and E viral proteins.
@nl
type
label
Monoclonal antibodies to SARS- ...... S, N, M and E viral proteins.
@ast
Monoclonal antibodies to SARS- ...... S, N, M and E viral proteins.
@en
Monoclonal antibodies to SARS- ...... S, N, M and E viral proteins.
@nl
prefLabel
Monoclonal antibodies to SARS- ...... S, N, M and E viral proteins.
@ast
Monoclonal antibodies to SARS- ...... S, N, M and E viral proteins.
@en
Monoclonal antibodies to SARS- ...... S, N, M and E viral proteins.
@nl
P2093
P50
P921
P1476
Monoclonal antibodies to SARS- ...... S, N, M and E viral proteins.
@en
P2093
Anthony Sanchez
Barbara Anderson
Congrong Miao
Deborah Moore
Donna M Ambrosino
Gregory J Babcock
Harold Alterson
James A Comer
Jennifer L Harcourt
Jonathan Smith
P356
10.1016/J.JVIROMET.2005.03.021
P577
2005-09-01T00:00:00Z